Menu
GeneBe

rs61752067

Variant summary

Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM1PM5PP3_StrongPP5_Very_Strong

The NM_000330.4(RS1):c.304C>T(p.Arg102Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000546 in 1,097,960 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 3 hemizygotes in GnomAD. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R102Q) has been classified as Pathogenic.

Frequency

Genomes: not found (cov: 22)
Exomes 𝑓: 0.0000055 ( 0 hom. 3 hem. )

Consequence

RS1
NM_000330.4 missense

Scores

12
4
1

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:7O:1

Conservation

PhyloP100: 3.00
Variant links:
Genes affected
RS1 (HGNC:10457): (retinoschisin 1) This gene encodes an extracellular protein that plays a crucial role in the cellular organization of the retina. The encoded protein is assembled and secreted from photoreceptors and bipolar cells as a homo-oligomeric protein complex. Mutations in this gene are responsible for X-linked retinoschisis, a common, early-onset macular degeneration in males that results in a splitting of the inner layers of the retina and severe loss in vision. [provided by RefSeq, Oct 2008]
CDKL5 (HGNC:11411): (cyclin dependent kinase like 5) This gene is a member of Ser/Thr protein kinase family and encodes a phosphorylated protein with protein kinase activity. Mutations in this gene have been associated with X-linked infantile spasm syndrome (ISSX), also known as X-linked West syndrome, and Rett syndrome (RTT). Alternate transcriptional splice variants have been characterized. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 16 ACMG points.

PM1
In a hotspot region, there are 7 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 7 uncertain in NM_000330.4
PM5
Other missense variant is known to change same aminoacid residue: Variant chrX-18647212-C-T is described in ClinVar as [Pathogenic]. Clinvar id is 9896.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.995
PP5
Variant X-18647213-G-A is Pathogenic according to our data. Variant chrX-18647213-G-A is described in ClinVar as [Likely_pathogenic]. Clinvar id is 9887.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-18647213-G-A is described in Lovd as [Pathogenic]. Variant chrX-18647213-G-A is described in Lovd as [Likely_pathogenic].

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
RS1NM_000330.4 linkuse as main transcriptc.304C>T p.Arg102Trp missense_variant 4/6 ENST00000379984.4
RS1XM_047442337.1 linkuse as main transcriptc.208C>T p.Arg70Trp missense_variant 2/4
CDKL5NM_001037343.2 linkuse as main transcriptc.2797+1123G>A intron_variant
CDKL5NM_003159.3 linkuse as main transcriptc.2797+1123G>A intron_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
RS1ENST00000379984.4 linkuse as main transcriptc.304C>T p.Arg102Trp missense_variant 4/61 NM_000330.4 P1
CDKL5ENST00000379989.6 linkuse as main transcriptc.2797+1123G>A intron_variant 1 O76039-1
CDKL5ENST00000379996.7 linkuse as main transcriptc.2797+1123G>A intron_variant 1 O76039-1
RS1ENST00000476595.1 linkuse as main transcriptn.795C>T non_coding_transcript_exon_variant 3/51

Frequencies

GnomAD3 genomes
Cov.:
22
GnomAD3 exomes
AF:
0.00000546
AC:
1
AN:
183299
Hom.:
0
AF XY:
0.00
AC XY:
0
AN XY:
67747
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000722
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000546
AC:
6
AN:
1097960
Hom.:
0
Cov.:
31
AF XY:
0.00000826
AC XY:
3
AN XY:
363368
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000713
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
Cov.:
22
ExAC
AF:
0.00000824
AC:
1
EpiCase
AF:
0.000164
EpiControl
AF:
0.00

ClinVar

Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:7Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Juvenile retinoschisis Pathogenic:4
Pathogenic, criteria provided, single submitterclinical testingVictorian Clinical Genetics Services, Murdoch Childrens Research InstituteOct 19, 2020Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with retinoschisis (MIM#312700). (I) 0109 - This gene is associated with X-linked recessive disease, however, some affected females have also been reported (OMIM) (I) 0200 - Variant is predicted to result in a missense amino acid change from arginine to tryptophan. (I) 0253 - This variant is hemizygous. (I) 0304 - Variant is present in gnomAD <0.01 for a recessive condition (v2: 1 heterozygote, 0 homozygotes, 0 hemizygotes). (SP) 0309 - An alternative amino acid change at the same position has been observed in gnomAD (v2) (1 heterozygote, 0 homozygotes, 0 hemizygotes). (I) 0501 - Missense variant consistently predicted to be damaging by multiple in silico tools and highly conserved with a major amino acid change. (SP) 0600 - Variant is located in the annotated coagulation factor 5/8 C-terminal domain (NCBI conserved domain). (I) 0702 – Other missense variants comparable to the one identified in this case have strong previous evidence for pathogenicity. The p.R102Q and p.R102P alternative variants have previously been reported as pathogenic in patients with retinoschisis (ClinVar, PMIDs: 30652005, 28272453). (SP) 0801 - This variant has strong previous evidence of pathogenicity in unrelated individuals. This variant has previously been reported as pathogenic in multiple individuals with retinoschisis (ClinVar, PMIDs: 9326935, 30652005, 30551202, 31725702). (SP) 0905 - No published segregation evidence has been identified for this variant. (I) 1002 - This variant has moderate functional evidence supporting abnormal protein function. This variant is result in a defect in protein secretion (PMID: 23453514). (SP) 1208 - Inheritance information for this variant is not currently available in this individual. (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign -
Pathogenic, no assertion criteria providedliterature onlyOMIMOct 01, 1997- -
Likely pathogenic, criteria provided, single submitterclinical testingInstitute of Medical Molecular Genetics, University of ZurichJan 30, 2021- -
Likely pathogenic, criteria provided, single submitterresearchOcular Genomics Institute, Massachusetts Eye and EarApr 08, 2021The RS1 c.304C>T variant was identified in an individual with retinitis pigmentosa with a presumed X-linked inheritance pattern. Through a review of available evidence we were able to apply the following criteria: PM2, PS3. Based on this evidence we have classified this variant as Likely Pathogenic. -
not provided Pathogenic:2Other:1
Pathogenic, criteria provided, single submitterclinical testingInvitaeDec 15, 2023This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 102 of the RS1 protein (p.Arg102Trp). This variant is present in population databases (rs61752067, gnomAD 0.008%). This missense change has been observed in individuals with X-linked juvenile retinoschisis (PMID: 9326935, 9618178, 16900931, 24634885, 30652005). ClinVar contains an entry for this variant (Variation ID: 9887). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt RS1 protein function with a positive predictive value of 95%. Experimental studies have shown that this missense change affects RS1 function (PMID: 12417531). This variant disrupts the p.Arg102 amino acid residue in RS1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 9618178, 17615541, 30652005). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. -
not provided, no classification providedliterature onlyRetina International-- -
Pathogenic, criteria provided, single submitterclinical testingGeneDxApr 28, 2017The R102W variant in the RS1 gene has been reported previously in association with X-linked retinoschisis (The Retinoschisis Consortium, 1998; Sauer CG et al. 1997; Huang et al. 2014; O'Sullivan et al. 2012). In vitro functional studies demonstrated that the presence of the R102W variant results in intracellularly retained misfolded protein (Vijayasarathy et al. 2010). Another in vitro functional study confirmed that the retinoschisin protein is not secreted when the R102W variant is present (Wang et al., 2002). The R102W variant was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The R102W variant is a non-conservative amino acid substitution that occurs at a position that is conserved across species. Therefore, we interpret R102W to be a pathogenic variant. -
Retinal dystrophy Pathogenic:1
Pathogenic, no assertion criteria providedclinical testingCentre for Genomic Medicine, Manchester, Central Manchester University HospitalsJan 30, 2015- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.79
BayesDel_addAF
Pathogenic
0.52
D
BayesDel_noAF
Pathogenic
0.70
Cadd
Pathogenic
26
Dann
Uncertain
1.0
DEOGEN2
Pathogenic
0.99
D
FATHMM_MKL
Uncertain
0.91
D
LIST_S2
Pathogenic
0.98
D
M_CAP
Pathogenic
0.82
D
MetaRNN
Pathogenic
0.99
D
MetaSVM
Pathogenic
1.1
D
MutationAssessor
Pathogenic
3.7
H
MutationTaster
Benign
1.0
A;A;A
PrimateAI
Uncertain
0.79
T
PROVEAN
Pathogenic
-7.8
D
REVEL
Pathogenic
0.96
Sift
Uncertain
0.0050
D
Sift4G
Pathogenic
0.0010
D
Polyphen
1.0
D
Vest4
0.98
MutPred
0.95
Loss of methylation at R102 (P = 0.0176);
MVP
1.0
MPC
1.7
ClinPred
0.99
D
GERP RS
4.6
Varity_R
0.94
gMVP
0.98

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs61752067; hg19: chrX-18665333; COSMIC: COSV66105902; API